Clinical Trial: A prospective, multicenter, randomized controlled, non-inferiority clinical study evaluating the efficacy and safety of the fully biodegradable oval fossa orifice closure device system for percutaneous interventional closure of patent foramen ovale (PFO) (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, multicenter, randomized controlled, non-inferiority clinical study evaluating the efficacy and safety of the fully biodegradable oval fossa orifice closure device system for percutaneous interventional closure of patent foramen ovale (PFO)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129453

Registration Time: 2026/08/05

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Naval Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336605

Published by HT Digital Content Services with permission fro...